Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
11/09/1999 | US5981541 Substituted heterocycles as anti-tumor agents |
11/09/1999 | US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders |
11/09/1999 | US5981539 Piperidine compounds as calcium channel blockers |
11/09/1999 | US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists |
11/09/1999 | US5981115 Recording layer comprises a resin an isocyanate compound crosslinked with resin, electron donating coloring agent and an electron accepting coloring developer |
11/09/1999 | CA2167912C Process for the preparation of sufentanil derivatives by carbene addition/aminolysis of 4-piperidone |
11/04/1999 | WO1999055704A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
11/04/1999 | WO1999055678A1 Quinoline derivatives |
11/04/1999 | WO1999055673A1 Arylphenyl-substituted cyclic keto enols |
11/04/1999 | WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
11/04/1999 | WO1999048894B1 Novel cephalotaxane derivatives and process for their preparation |
11/04/1999 | CA2329434A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
11/02/1999 | US5977169 Substituted tetronic acids useful for treating HIV and other retroviruses |
11/02/1999 | US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
11/02/1999 | US5977106 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives |
10/28/1999 | WO1999054330A1 2,3-olefinic epothilone derivatives |
10/28/1999 | WO1999054319A1 12,13-modified epothilone derivatives |
10/28/1999 | WO1999054318A1 12,13-cyclopropane epothilone derivatives |
10/28/1999 | WO1999054303A1 Optically active tetrahydrobenzindole derivatives |
10/28/1999 | WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
10/28/1999 | WO1999043654A3 Inhibitors of phospholipase enzymes |
10/28/1999 | DE19818732A1 New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides |
10/28/1999 | DE19808261A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols |
10/28/1999 | CA2329413A1 2,3-olefinic epothilone derivatives |
10/28/1999 | CA2329319A1 Optically active tetrahydrobenzindole derivatives |
10/28/1999 | CA2323609A1 12,13-cyclopropane epothilone derivatives |
10/27/1999 | CN1233239A Process for preparing 2-azadihydroxybicyclo [2,2,1] heptane compounds and the L-tartaric acid salt of the compound |
10/27/1999 | CN1045962C Pyridopyridazinone or pyridopyridazine-thione compound, intermediate for preparing it, pharmaceutical composite containing the same and its use |
10/27/1999 | CN1045957C Tricyclic benzazepine, their application and preparation |
10/26/1999 | US5973085 Monomers and composition which can be crosslinked and crosslinked polymers |
10/26/1999 | US5972979 Tricyclic spiro compounds as 5HT1D receptor antagonists |
10/26/1999 | US5972970 Oxazolidinedione derivatives, their production and use |
10/26/1999 | US5972955 Water soluble C-ring analogues of 20(S)-camptothecin |
10/26/1999 | US5972951 Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists |
10/26/1999 | US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder |
10/26/1999 | CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
10/21/1999 | WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
10/21/1999 | WO1999052888A1 Butenolide derivatives as anti-cancer agents |
10/21/1999 | WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application |
10/21/1999 | WO1999052871A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element |
10/21/1999 | WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis |
10/21/1999 | WO1999026927A3 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
10/21/1999 | CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
10/20/1999 | EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases |
10/20/1999 | EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
10/20/1999 | EP0950054A1 Substituted heterocycles as anti-tumor agents |
10/20/1999 | EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
10/20/1999 | EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
10/20/1999 | CN1232450A 2- and 2,5-substd. phenylketoenols |
10/19/1999 | US5969150 Fluorescent compounds for medical diagnosis, drugs and labels or fungicides and viricides |
10/19/1999 | US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins |
10/19/1999 | US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease |
10/19/1999 | US5968954 Exhibit selective binding affinity for 5-hydroxytryptamine receptors |
10/19/1999 | US5968943 Derivatives of camptothecin and methods of treating cancer using these derivatives |
10/19/1999 | US5968937 For treatment and/or prevention of hypertension, cardiac insufficiency, coronary vasospasm, cardiac ischemia, renal vasospasm, liver cirrhosis, congestive heart failure, nephrotic syndrome, brain edema, cerebral ischemia |
10/19/1999 | US5968930 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
10/17/1999 | CA2269256A1 Substituted tricyclics |
10/14/1999 | WO1999051229A1 Treatment of panic attacks |
10/14/1999 | DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma |
10/14/1999 | CA2325948A1 Treatment of panic attacks |
10/13/1999 | EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
10/12/1999 | US5965728 Process for the preparation of a salt clavulanic acid |
10/12/1999 | US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues |
10/12/1999 | US5965566 High molecular weight polymer-based prodrugs |
10/07/1999 | WO1999050253A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
10/07/1999 | WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof |
10/07/1999 | CA2322203A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
10/06/1999 | EP0947514A1 Novel phenanethridinium derivatives |
10/06/1999 | EP0947513A1 Tricyclic amine derivatives |
10/06/1999 | EP0946569A2 Cycloaliphatic epoxy compounds |
10/06/1999 | EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
10/06/1999 | EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines |
10/06/1999 | EP0946564A1 New process for the preparation of morphinans |
10/06/1999 | EP0946556A1 Combinatorial process for preparing hydrofuroquinoline libraries |
10/06/1999 | EP0946542A1 Indane or dihydroindole derivatives |
10/06/1999 | EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
10/06/1999 | CN1230948A Pyranoindole and carbazole inhibitors of COX-2 |
10/05/1999 | US5962499 Acaricidal, antiparasitic, insecticidal and anthelmintic agents |
10/05/1999 | US5962469 Cyclic nitrones |
10/05/1999 | US5962467 Derivatives of swainsonine and their use as therapeutic agents |
10/05/1999 | US5962465 Brain disorders; psychological disorders |
10/05/1999 | US5962462 Spiro-substituted azacycles as modulators of chemokine receptor activity |
10/05/1999 | US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones |
09/30/1999 | WO1999048894A1 Novel cephalotaxane derivatives and process for their preparation |
09/30/1999 | WO1999048869A1 Aryl phenyl substituted cyclic ketoenols |
09/30/1999 | DE19813354A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols |
09/30/1999 | CA2324895A1 Novel cephalotaxane derivatives and process for their preparation |
09/29/1999 | EP0944633A1 Substituted phenylketoenols and their use as pesticides and herbicides |
09/29/1999 | EP0944386A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
09/29/1999 | EP0944385A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING $i(HELICOBACTER PYLORI) INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH |
09/29/1999 | CN1230188A 25-methylene and 24,25-epoxy marcfortines and paraheroquamides |
09/28/1999 | US5959116 Pyridine-2, 3-dicarboximides their preparation and their use for controlling undesired plant growth |
09/28/1999 | US5959110 Substituted tetrahydro-1h-naph(1,2,3-de)isoquinoline compound useful for treating nervous system disorders |
09/28/1999 | US5958970 Tricyclic and tetracyclic pyrones |
09/28/1999 | US5958936 For inducing antiandrogenic activity in warm-blooded animals, including humans |
09/28/1999 | US5958930 Treating cancer, and secondary infections caused by pneumocystis carinii and toxoplasmosis gondii in immunocompromised patients. |
09/28/1999 | US5958903 Cholinesterase inhibitors |
09/28/1999 | US5958792 Combinatorial libraries of substrate-bound cyclic organic compounds |
09/22/1999 | EP0942911A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
09/22/1999 | EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |